Tweets
ICYMI: Nice full read review of IL-23 in Rheumatology - its biology and clinical targeting. IL-23 is a coordinating cytokine in psoriasis, psoriatic arthritis and inflammatory bowel disease. https://t.co/tDWZuV6Tao https://t.co/0p8RGnnE9B
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
ICYMI: Propensity matched comparison of Tramadol vs Codeine use. Tramadol had a signif. higher risk of all-cause mortality (HR, 2.31), CV events (HR 1.15) & fractures (HR 1.50), but no diff in falls, delirium, constipation, opioid abuse, sleep disorders. https://t.co/nBUe5VV1D3 https://t.co/C3r0Fur4xJ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Congratulations to friend and mentor, Dr. Stan Cohen for receiving this years ACR Gold Medal award - the highest award that the ACR can bestow. Stan was a past ACR President & has been a leading educator and researcher in rheumatology https://t.co/EJQ5tc3dhc
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
ICYMI:Pregabalin (lyrica) for Fibromyalgia 75 mg bid; may be increased to max dose 450 mg/d.(Reduce for renal dz). Indications: DM neuropathy/pain, post-herpetic neuralgia, partial seizures. Rare AE: Angioedema, low Plts, ^PR interval, rhabdo, gynecomastia https://t.co/r4cH7n9qWD
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
ICYMI: B-cell depletion therapy with obinutuzumab, a type II anti-CD20 monoclonal antibody, in lupus nephritis patients was shown to be effective in in combination with standard lupus therapies.
https://t.co/pMXWmuJw5Y https://t.co/RhWdVir6yB
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
ICYMI: FDA Approves Cyltezo, the 1st INTERCHANGEABLE Biosimilar to Humira - interchangeable means this biosimilar may be substituted for the Humira without the prescriber notice (by pharmacy)in same way generics are substituted for brand name drugs https://t.co/xvinL7UKNU https://t.co/8y5asZ7NWq
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
New podcast up! Rheumatologist Smoke-Enders
https://t.co/o35tuNgk8R https://t.co/iEqVoggl32
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Insights
Read the full article on #RheumNow
https://t.co/294Au0Q1c3 https://t.co/c1X2T5G4jW
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
RECOVERY study of hospitalized COVID-19 pts compared colchicine to PBO (+usual care). Colchicine had no effect on 28d mortality (21% vs 21%), time to D/C(10 d vs 10d), LIve D/C (70 vs 70%), mechanical vent or death (25 vs 25%) https://t.co/dYZglKzwxC
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Nice full read review of IL-23 in Rheumatology - its biology and clinical targeting. IL-23 is a coordinating cytokine in psoriasis, psoriatic arthritis and inflammatory bowel disease. https://t.co/tDWZuV6Tao
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Propensity matched comparison of Tramadol vs Codeine use. Tramadol had a signif. higher risk of all-cause mortality (HR, 2.31), CV events (HR 1.15) & fractures (HR 1.50), but no diff in falls, delirium, constipation, opioid abuse, sleep disorders. https://t.co/nBUe5VV1D3 https://t.co/DHzrXQ2nr1
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
September’s most popular read:
11 Drugs That Cause Arthritis
https://t.co/GsV0Qj9ENr https://t.co/DNI9bqgKym
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
